Get the tools used by (smart)2 investors.

Predicted Fwd P/E Ratio (FY+2) for Novartis AG

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

0QLR: Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

97.98 CHF
Price
CHF
Fair Value
Upside
83.61 - 115.98
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Novartis AG's Predicted Fwd P/E Ratio (FY+2):

0QLRHLTH.CHSDZ010683053RO0009439810.0x5.0x10.0x15.0x

Performance Summary
  • Novartis's predicted fwd p/e ratio (fy+2) is 13.0x

Benchmarks

Metric Usage: Predicted Fwd P/E Ratio (FY+2)

Hide this widget
prediction_pe_fwd2
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Predicted Fwd P/E Ratio (FY+2) in the predictions category include:

View Full List

Search for metric or datapoint

Predicted Fwd P/E Ratio (FY+2)

Our estimate of the fair value Fwd P/E Ratio (FY+2) for a company.

Definition of Predicted Fwd P/E Ratio (FY+2)

Sector Benchmark Analysis

All rights reserved. Terms Of Use